| 中文名称 | 他克莫司一水合物 |
|---|---|
| 中文别名 | 他克莫司一水合物;3-甲基噻吩-2-甲基胺;Tacrolimus Monohydrate 他克莫司一水合物;他克莫司;他克莫司 USP标准品;他克莫司水合物;FK-506一水合物;大环哌喃;他克莫斯;泰克利马;FK-506 一水合物 |
| 英文名称 | Tacrolimus monohydrate |
| 英文别名 | Tacrolimus monohydrate;TACROLIMUS;FK-506 monohydrate;C44H71NO13;FK 506;FK-506;Tacrolimus hydrate;TacroliMus(FK-506);FK 506 Monohydrate;FK-506 monohydrate,Tacrolimus;FR900506 monohydrate;Fujimycin monohydrate;Prograf;Protopic;Fujimycin;Tsukubaenolide;FK506;Tacrolimus anhydrous;Modigraf;Protopy;LCP-Tacro;Anhydrous Tacrolimus;tacrolimus (fk506);Advagraf;8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN;K506;Astagraf XL;Prograf (TN);FR900506;Tacarolimus;FR 900506;Y5L2157C4J;FK5;Tacrolimus (anhydrous);Prograft;Tacrolimus [USAN];Graceptor;Envarsus;Avagraf;L 679934;Envarsu;Tsukubaenolide hydrate;Tacrolimus (monohydrate);WM0HAQ4WNM;FK506 monohydrate;Tacrolimus for system suitability, European Pharmacopoeia (EP) Reference Standard;(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0,4,9]octacos-18-ene-2,3,10,16-tetrone hydrate;UNII-WM0HAQ4WNM;CHEMBL3989887;GLXC-02501;TACROLIMUS [USP MONOGRAPH];SCHEMBL317005;HY-13756A;TACROLIMUS MONOHYDRATE [EP MONOGRAPH];TACROLIMUS [VANDF];Q27130595;EN300-220769;AKOS015994743;TACROLIMUS MONOHYDRATE [WHO-DD];TACROLIMUS [USP-RS];FK-506 monohydrate, >=98% (HPLC);Tacrolimus, United States Pharmacopeia (USP) Reference Standard;Tacrolimus hydrate (JP18);EX-A2657;NSC-758659;TACROLIMUS [EMA EPAR];NWJQLQGQZSIBAF-MLAUYUEBSA-N;15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-, hydrate (1:1), (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-;AC-32477;Tacrolimus, Pharmaceutical Secondary Standard; Certified Reference Material;Protopic (TN);TACROLIMUS [ORANGE BOOK];Tacrolimus (USP/INN);(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone;hydrate;109581-93-3;EN300-21682061;(-)-(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone monohydrate;(-)-(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-8-allyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,19-dihydroxy-3-((E)-2-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-1-methylvinyl)-14,16-dimethoxy-4,10,12,18-tetramethyl-15,19-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone)monohydrate;D001... |
| CAS No. | 109581-93-3 |
| 分子式 | C44H71NO13 |
| 分子量 | 822.03 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学